Invitae Completes Sale of Reproductive Health Assets to Natera

SAN FRANCISCO, Jan. 22, 2024 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has completed the sale of certain reproductive health assets, which include carrier screening and non-invasive prenatal screening, to Natera (NASDAQ: NTRA). The value…

Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks